Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines

Idiosyncratic drug-induced liver injury mimics acute and chronic liver disease. It is under recognized and underrecognised because of the lack of pathognomonic diagnostic serological markers. Its consequences may vary from being asymptomatic to self-limiting illness to severe liver injury leading to...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Hepatology international Ročník 15; číslo 2; s. 258 - 282
Hlavní autori: Devarbhavi, Harshad, Aithal, Guruprasad, Treeprasertsuk, Sombat, Takikawa, Hajime, Mao, Yimin, Shasthry, Saggere M., Hamid, Saeed, Tan, Soek Siam, Philips, Cyriac Abby, George, Jacob, Jafri, Wasim, Sarin, Shiv K.
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: New Delhi Springer India 01.04.2021
Springer Nature B.V
Predmet:
Colorectal Surgery
Guidelines
Hepatology
Hepatotoxicity
Injury prevention
Liver
Liver diseases
Liver failure
Medical treatment
Medicine
Medicine & Public Health
Surgery
Tuberculosis
Asia
DILI
Consensus
Risk factors
Guidelines
Traditional and complimentary medicine
APASL
Tuberculosis
Treatment
Medications
Drug-induced liver injury
Antituberculosis drugs
Hepatotoxicity
Monitoring
ISSN:1936-0533, 1936-0541, 1936-0541
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Idiosyncratic drug-induced liver injury mimics acute and chronic liver disease. It is under recognized and underrecognised because of the lack of pathognomonic diagnostic serological markers. Its consequences may vary from being asymptomatic to self-limiting illness to severe liver injury leading to acute liver failure. Its incidence is likely to be more common in Asia than other parts of the world, mainly because of hepatotoxicity resulting from the treatment of tuberculosis disease and the ubiquitous use of traditional and complimentary medicines in Asian countries. This APASL consensus guidelines on DILI is a concise account of the various aspects including current evidence-based information on DILI with special emphasis on DILI due to antituberculosis agents and traditional and complementary medicine use in Asia.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1936-0533
1936-0541
1936-0541
DOI:10.1007/s12072-021-10144-3